Vaccination is the most effective method of controlling seasonal influenza infections and preventing possible pandemic events. Although influenza vaccines have been licensed and used for decades, the potential correlates of protection induced by these vaccines are still a matter of discussion. Currently, inactivated vaccines are the most common and the haemagglutination inhibition antibody titer is regarded as an immunological correlate of protection and the best available parameter for predicting protection from influenza infection. However, the assay shows some limitations, such as its low sensitivity to B and avian strains and inter-laboratory variability. Additional assays and next-generation vaccines have been evaluated to overcome the limitations of the traditional serological techniques and to elicit broad immune responses, underlining the need to revise the current correlates of protection. The aim of this review is to provide an overview of the current scenario regarding the immunological evaluation and correlates of protection of influenza vaccines.
Trombetta, C.M., Montomoli, E. (2016). Influenza immunology evaluation and correlates of protection: a focus on vaccines. EXPERT REVIEW OF VACCINES, 15(8), 967-976 [10.1586/14760584.2016.1164046].
Influenza immunology evaluation and correlates of protection: a focus on vaccines
Trombetta, Claudia Maria;Montomoli, Emanuele
2016-01-01
Abstract
Vaccination is the most effective method of controlling seasonal influenza infections and preventing possible pandemic events. Although influenza vaccines have been licensed and used for decades, the potential correlates of protection induced by these vaccines are still a matter of discussion. Currently, inactivated vaccines are the most common and the haemagglutination inhibition antibody titer is regarded as an immunological correlate of protection and the best available parameter for predicting protection from influenza infection. However, the assay shows some limitations, such as its low sensitivity to B and avian strains and inter-laboratory variability. Additional assays and next-generation vaccines have been evaluated to overcome the limitations of the traditional serological techniques and to elicit broad immune responses, underlining the need to revise the current correlates of protection. The aim of this review is to provide an overview of the current scenario regarding the immunological evaluation and correlates of protection of influenza vaccines.File | Dimensione | Formato | |
---|---|---|---|
059-2016_ERV-Trombetta.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
981.51 kB
Formato
Adobe PDF
|
981.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
postprinttrombetta1008647.pdf
accesso aperto
Tipologia:
Post-print
Licenza:
Creative commons
Dimensione
422.71 kB
Formato
Adobe PDF
|
422.71 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1008647